Founded in 2011, Nestlé Health Science (NHSc) is a globally recognized leader in the field of nutritional science, committed to redefining the management of health. We offer an extensive portfolio of science-based consumer health, medical nutrition, supplement brands, and pharmaceutical therapies.
NHSc is headquartered in Switzerland and we have more than 5,000 employees around the world, with a presence in 66 countries.
Approximately half of our business is dedicated to medical nutrition (products that are available only through healthcare providers) and half is dedicated to consumer care, or over-the-counter, nutritional solutions. We cover the spectrum from newborns to the most senior citizens, from individuals looking to enhance their fitness performance to those that need extra special nutritional care due to illnesses.
Our medical nutrition portfolio includes products and services recommended by healthcare professionals for patients with specific dietary needs related to illnesses, disease states or special challenges of different life stages. These products are most relevant for the institutional sector – including hospitals, long- and short-term care facilities, and homecare – and are typically reimbursed by insurers or public health services. The current portfolio is focused on Pediatric Care & Food Allergy, Adult Medical Care and Acute Care.
Consumers are increasingly health-aware and informed, looking for nutritional solutions to help them lead healthier lives. In consumer care, we are combining science-based innovation and global reach to address individuals’ unmet and emerging needs. Our products are found in pharmacies, retail shops and on the internet. We are focused on the fast-developing areas of healthy aging, healthy growth, gut health and metabolic health, obesity in particular.
In 2020, we expanded our portfolio to include medicinal therapies. Through the acquisition of Aimmune Therapeutics, we have established a global pharmaceutical business focused on treatments for potentially life-threatening food allergies and other food-mediated conditions, including gastrointestinal conditions. We also acquired Zenpep® and Viokace®, medications for the treatment of Exocrine Pancreatic Insufficiency (EPI) due to cystic fibrosis or other conditions. They are for people who cannot digest food normally because their pancreas does not make enough enzymes. Our experience in cystic fibrosis, gastrointestinal disease and other therapeutic areas for ZENPEP and VIOKACE give us a good understanding of patients’ needs, and our solid network of healthcare professionals allows us to provide education on these medications.
Our commitment to science-backed solutions and research means that we provide nutritional solutions that can make a real difference in the quality of life of customers, patients and caregivers. Our Nestlé Product Technology Center in Bridgewater, New Jersey, opened in 2018 and allows us to further strengthen our commitment to harness the power of nutrition to empower healthier lives.
Nutritional health is a broad and fast-growing market and we see many opportunities in it for Nestlé Health Science. Over the years we have acquired businesses which have innovative ideas, promising strategies, high-quality products, and expertise and capabilities complementary to ours, all of which will help further our mission to empower healthier lives through nutrition. These business are integrated into NHSc, operating with the same values and commitments, but they retain a level of independence when it comes to their sourcing, production and customer relations – the same independence that made them so successful in the first place.
Aimmune Therapeutics is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies and other food-mediated conditions, including gastrointestinal conditions. Aimmune was founded to address the need for approved treatments for food allergies, starting with peanut allergy. Building on more than a century of research on oral immunotherapy for food allergy, Aimmune uses rigorous science and a structured approach called CODIT™ (Characterized Oral Desensitization Immunotherapy) to develop first-in-class complex biologic immunotherapies that combine the rigor of an FDA-regulated medication with well-characterized allergen profiles. In 2020, Aimmune became the first company to have a treatment for peanut allergy that is both FDA and EU-approved. Aimmune’s development pipeline also includes investigational candidates for other prevalent food allergies, including multi-tree nut. For more information, visit www.aimmune.com.
Atrium Innovations is a recognized innovative leader in the development, manufacturing, and commercialization of science-based nutritional and supplement health products. The company’s mission is to be a global leader in vitamins, minerals and supplements, offering trusted, free from, science-based nutritional solutions for consumers, patients, doctors, nurses, and other partners in healthcare. Atrium Innovations Professional brands include Garden of Life®, Pure Encapsulations®, Douglas Laboratories®, Genestra BrandsTM, KLEAN Athlete®, LivingMatrixTM, Orthica®, PharmaxTM, TrophicTM, Minami Nutrition®, AOV®, and Wobenzym®.
Persona uses its direct-to-consumer sales model to take the guesswork and confusion out of vitamins and supplements by creating a truly personalized vitamin program. Through its free online assessment, Persona asks about a person’s lifestyle, fitness levels, dietary preferences and prescription medication use ( to determine any drug-nutrient interactions) to deliver high-quality and science-backed nutritional supplements in customized daily packs directly to a customer’s doorstep every month. www.mypersona.com.
Vitaflo provides uniquely formulated products that address various inherited metabolic disorders that become apparent shortly after birth. Metabolic disorders result from a lack of necessary enzymes to break down the fat, carbohydrates or protein in foods, resulting in serious medical problems and often requiring a specialized diet and nutritional solutions for life.
Creating Shared Value
Creating Shared Value (CSV) is a fundamental part of the Nestlé way of doing business. CSV focuses on creating value for society and all stakeholders in our business, through sourcing, manufacturing and distribution.
Sustainability is built into everything we do and as part of the Nestlé Group, we are committed to zero greenhouse gas emissions by 2050.
We partner with the vast Nestlé R&D network located in 23 centers around the world, and with The Nestlé Nutrition Institute which shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders, in an interactive way.